Article
Novo Nordish and Eli Lilly cash in on blockbuster weight-loss drugs | CNN Business
Rating:
0.0
Views:
58
Likes:
1
Library:
1
On Thursday, Novo Nordisk, the company behind Ozempic and Wegovy, reported a 29% increase in sales to $8.4 billion for the third quarter. Eli Lilly, which makes diabetes drug Mounjaro, reported a 37% revenue increase to $9.5 billion in the third quarter.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value